News & Events

  • November 30, 2012

    Ireland Inc. announced the closing of their Registered Direct offering in the amount of $5,782,991.  EG&S acted as counsel to the Placement Agent.

  • November 30, 2012

    Morria Biopharmaceuticals PLC announced the closing of their Registered Direct offering in the amount of $1,503,000.  EG&S acted as counsel to the Placement Agent.

  • November 29, 2012

    United Riverhead Terminal, Inc. announced the closing of its acquisition of an oil storage terminal in Riverhead, NY from Phillips 66 Company.  EG&S acted as counsel to United.

  • November 27, 2012

    T3 Motion, Inc. announced the closing of their PIPE offering in the amount of $4,353,250.  EG&S acted as counsel to the Placement Agent.

  • November 26, 2012

    Arno Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $12,000,000.  EG&S acted as counsel to the Investor.

  • November 14, 2012

    ESP Resources, Inc. announced the closing of their PIPE offering in the amount of $1,000,000.  EG&S acted as counsel to the Investor.

  • November 09, 2012

    EG&S is proud to represent BioDelivery Sciences International (BDSI) - the number 1 performing company on the Russell 3,000 year to date.
     

  • November 02, 2012

    CLIENT ALERT

    As most of you already know, the North East was hit by hurricane Sandy earlier in the week.  It has left many without power, flooded, without transportation and with damage to their homes.  At this time, everyone is in the process of recovering, including EG&S.  We are operating efficiently but our phones are down. The best way to reach us is by e-mail, preferably, and by our attorneys' cell phones. 

    And to those of you who also reside in the North East, our hearts go out to you and your families. 

    We appreciate and thank you for your patience during this time.

  • October 24, 2012

    Collabrium Japan Acquisition Corporation (Nasdaq: JACQU) announced the closing of their SPAC IPO in the amount of $40,000,000. EG&S acted as counsel to The PrinceRidge Group LLC, the underwriter of the offering.

  • October 08, 2012

    Trig Acqusition 1, Inc., held an initial closing in the amount of $1,050,000 regarding a best efforts private placement offering of up to $5,000,000. Grandview Capital Partners Inc. acted as placement agent for the offering. Simultaneous with the initial closing of the Offering, Trig Acquisition 1, Inc. also entered into a share exchange agreement whereby it acquired, through a reverse merger, Grilled Cheese Inc. EG&S represented the placement agent in the alternative public offering.

  • October 03, 2012

    RLJ Acquisition Inc. Announces Succesful Completion of its Business Combination

    RLJ Acquisition, Inc., a special purpose acquisition vehicle, announced the closing of its business combination with Image Entertainment, Inc. and Acorn Media Group, Inc., two media content distribution companies, to form RLJ Entertainment, Inc., one of the largest independent global distributors of digital and video content. EG&S acted as counsel to Image’s Special Committee.

    RLJ Companies, October 3, 2012

  • October 01, 2012

    CombiMatrix Corporation announced the closing of their Private Placement offering in the amount of $1,050,875.49.  EG&S acted as counsel to the Investor.

  • October 01, 2012

    Wealth Management Systems Inc. announced the closing of its acquisition of 100% of the equity interests in Archimedes Systems, Inc.  EG&S acted as counsel to Wealth Management.

  • September 14, 2012

    Hemispherx Biopharma, Inc. announced the closing of their At the Market Offering in the amount of $75,000,000.  EG&S acted as counsel to the Selling Agent.
     

  • September 10, 2012

    rVue Holdings, Inc. announced the closing of their  PIPE financing in the amount of $1,200,000 and concurrent conversion of $1,800,000 of debt.  EG&S acted as counsel to rVue.

  • September 05, 2012

    In response to FINRA’s proposed guidelines, Ellenoff Grossman & Schole LLP has submitted the comment letter below.

    Click here to read the comment letter

  • September 05, 2012

    Crowdfund Capital Advisors has written a whitepaper titled "How Crowdfund Investing Helps Solve Three Pressing Socioeconomic Challenges."  EG&S sponsored the whitepaper.

    Click here to read the whitepaper

  • August 20, 2012

    BioSante Pharmaceuticals, Inc. announced the closing of their Registered Direct offering in the amount of $3,474,999. EG&S acted as counsel to the placement agent.

  • August 15, 2012

    Arrowhead Research Corp. announced the closing of their Registered Direct offering in the amount of $6,240,000.  EG&S acted as counsel to the placement agent.

  • August 14, 2012

    Generex Biotechnology Corporation announced the closing of their Registered Direct offering in the amount of $750,000.  EG&S acted as counsel to the Investor.

  • August 13, 2012

    Eco Building Products, Inc. announced the closing of their PIPE offering in the amount of $1,080,000.  EG&S acted as counsel to the Investor.

  • August 08, 2012

    ARCA biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $952,710.  EG&S acted as counsel to the placement agent.

  • August 07, 2012

    pSivida Corp. announced the closing of their Registered Direct offering in the amount of $5,363,000. EG&S acted as counsel to the placement agent.

  • August 06, 2012

    Stevia Corp. announced the closing of their PIPE offering in the amount of $500,000.  EG&S acted as counsel to the Investor.

  • July 31, 2012

    NutraCea announced the closing of their PIPE offering in the amount of $290,000.  EG&S acted as counsel to the Investor.